This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, Institut Pasteur, National Institute of Health and Medical Research. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 5,383 
1 out of 899 
1 out of 1,853 
Years Active: 2016
Title: Carolina Armengol Niell: Innovator in Liver Tumor Research
Introduction
Carolina Armengol Niell is a prominent inventor based in Blanes, Spain. She has made significant contributions to the field of medical research, particularly in the area of liver tumors. Her innovative work has led to the development of a patented method that aids in the evaluation of liver tumor grades and prognosis.
Latest Patents
Carolina holds a patent titled "Molecular signature of liver tumor grade and use to evaluate prognosis and therapeutic regimen." This invention concerns a method to determine the gene expression profile from a sample obtained from a patient diagnosed with a liver tumor. The method involves assaying the expression of a set of genes in the sample and determining the gene expression profile, or signature. This approach enables the determination of the grade of liver tumors, such as hepatoblastoma (HB) or hepatocellular carcinoma (HCC). Additionally, the invention includes kits comprising a plurality of pairs of primers or probes specific for a set of genes, which are useful for assessing the risk of metastasis and defining therapeutic regimens for patients.
Career Highlights
Throughout her career, Carolina has worked with esteemed institutions such as the National Institute of Health and Medical Research and the Centre National De La Recherche Scientifique. Her research has been pivotal in advancing the understanding of liver tumors and improving patient outcomes.
Collaborations
Carolina has collaborated with notable colleagues, including Marie-Annick Buendia and Stefano Cairo. These partnerships have enriched her research and contributed to the success of her innovative projects.
Conclusion
Carolina Armengol Niell is a trailblazer in the field of liver tumor research, with her patented methods offering valuable insights into tumor grading and treatment. Her work exemplifies the impact of innovation in medical science, ultimately benefiting patient care and therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile